Upregulated expression of BCL2, MCM7, and CCNE1 indicate cisplatin-resistance in the set of two human bladder cancer cell lines: T24 cisplatin sensitive and T24R2 cisplatin resistant bladder cancer cell lines

PURPOSE: The mechanism of resistance to cisplatin during treatment of bladder cancer (BC) has been a subject of intense investigation in clinical research. This study aims to identify candidate genes associated with resistance to cisplatin, in order to understand the resistance mechanism of BC cells...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Investig Clin Urol
Autores principales: Kim, Sung Han, Ho, Jin-Nyoung, Jin, Hyunjin, Lee, Sang Chul, Lee, Sang Eun, Hong, Sung-Kyu, Lee, Jeong Woo, Lee, Eun-Sik, Byun, Seok-Soo
Formato: Artigo
Lenguaje:Inglês
Publicado: The Korean Urological Association 2016
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4778756/
https://ncbi.nlm.nih.gov/pubmed/26966728
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4111/icu.2016.57.1.63
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares